Deciphera Pharmaceuticals Inc (DCPH)
25.46
+0.02
(+0.06%)
USD |
NASDAQ |
May 17, 16:00
25.46
0.00 (0.00%)
After-Hours: 20:00
Deciphera Pharmaceuticals Accounts Receivable (Quarterly): 32.68M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 32.68M |
| December 31, 2023 | 31.95M |
| September 30, 2023 | 27.55M |
| June 30, 2023 | 23.20M |
| March 31, 2023 | 22.44M |
| December 31, 2022 | 22.43M |
| September 30, 2022 | 23.28M |
| June 30, 2022 | 25.85M |
| March 31, 2022 | 23.15M |
| December 31, 2021 | 20.60M |
| Date | Value |
|---|---|
| September 30, 2021 | 18.05M |
| June 30, 2021 | 18.61M |
| March 31, 2021 | 21.82M |
| December 31, 2020 | 13.90M |
| September 30, 2020 | 11.81M |
| June 30, 2020 | 7.384M |
| March 31, 2020 | |
| December 31, 2019 | 0.00 |
| September 30, 2019 | |
| June 30, 2019 | 20.00M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2019
32.68M
Maximum
Mar 2024
20.26M
Average
22.12M
Median
Accounts Receivable (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 8.826B |
| Dynavax Technologies Corp | 44.16M |
| Gilead Sciences Inc | 4.669B |
| Esperion Therapeutics Inc | 54.61M |
| SINTX Technologies Inc | 0.483M |